These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 25401215

  • 1. Persistent endothelial damage after intravenous immunoglobulin therapy in Kawasaki disease.
    Sakurai Y, Takatsuka H, Onaka M, Takada M, Nishino M.
    Int Arch Allergy Immunol; 2014; 165(2):111-8. PubMed ID: 25401215
    [Abstract] [Full Text] [Related]

  • 2. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
    Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
    [Abstract] [Full Text] [Related]

  • 3. Elevated D-dimer level is a risk factor for coronary artery lesions accompanying intravenous immunoglobulin-unresponsive Kawasaki disease.
    Masuzawa Y, Mori M, Hara T, Inaba A, Oba MS, Yokota S.
    Ther Apher Dial; 2015 Apr; 19(2):171-7. PubMed ID: 25257673
    [Abstract] [Full Text] [Related]

  • 4. Involvement of the ADAMTS13-VWF axis in acute Kawasaki disease and effects of intravenous immunoglobulin.
    Tsujii N, Nogami K, Matsumoto M, Yoshizawa H, Takase T, Tanaka I, Sakai T, Fukuda K, Hayakawa M, Sakai K, Isonishi A, Matsuura K, Fujimura Y, Shima M.
    Thromb Res; 2019 Jul; 179():1-10. PubMed ID: 31055186
    [Abstract] [Full Text] [Related]

  • 5. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
    Hu P, Jiang GM, Wu Y, Huang BY, Liu SY, Zhang DD, Xu Y, Wu YF, Xia X, Wei W, Hu B.
    Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
    [Abstract] [Full Text] [Related]

  • 6. Altered immunoglobulin A and M levels associated with changes in BAFF and APRIL after administration of intravenous immunoglobulin to treat Kawasaki disease.
    Doi M, Takeda T, Sakurai Y, Kato J, Hayashi T, Fukuda K, Takase T, Shima M.
    J Investig Allergol Clin Immunol; 2010 Aug; 20(5):413-8. PubMed ID: 20945608
    [Abstract] [Full Text] [Related]

  • 7. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC, Lo MH, Hsieh KS, Guo MM, Huang YH.
    PLoS One; 2015 Aug; 10(12):e0144603. PubMed ID: 26658843
    [Abstract] [Full Text] [Related]

  • 8. Predictive value of coagulation profiles for both initial and repeated immunoglobulin resistance in Kawasaki disease: A prospective cohort study.
    Shao S, Yang L, Liu X, Liu L, Wu M, Deng Y, Duan H, Li Y, Hua Y, Luo L, Zhou K, Wang C.
    Pediatr Allergy Immunol; 2021 Aug; 32(6):1349-1359. PubMed ID: 33694279
    [Abstract] [Full Text] [Related]

  • 9. Immunoglobulin G values before treatment are correlated with the responsiveness to initial intravenous immunoglobulin therapy for Kawasaki disease.
    Yanagimoto K, Nomura Y, Masuda K, Hirabayashi M, Morita Y, Yoshishige M, Ueno K, Eguchi T, Kawano Y.
    Int Arch Allergy Immunol; 2014 Aug; 164(2):83-8. PubMed ID: 24903098
    [Abstract] [Full Text] [Related]

  • 10. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM, Silverman ED, McCrindle BW, Yeung RS.
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [Abstract] [Full Text] [Related]

  • 11. [Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease].
    Liu F, Ding Y, Yin W.
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1109-12. PubMed ID: 24342209
    [Abstract] [Full Text] [Related]

  • 12. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
    Uehara R, Belay ED, Maddox RA, Holman RC, Nakamura Y, Yashiro M, Oki I, Ogino H, Schonberger LB, Yanagawa H.
    Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
    [Abstract] [Full Text] [Related]

  • 13. Expression of receptor for advanced glycation end products (RAGE) on the surface of circulating endothelial cells is upregulated in Kawasaki disease.
    Gong F, Zhang Y, Xie C, Zhu W, Wang W, Fu S, Shen H.
    Pediatr Res; 2012 Jun; 71(6):720-4. PubMed ID: 22337222
    [Abstract] [Full Text] [Related]

  • 14. Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
    Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y.
    Arch Dis Child; 2008 Feb; 93(2):142-6. PubMed ID: 17962370
    [Abstract] [Full Text] [Related]

  • 15. Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease.
    Abe J, Ebata R, Jibiki T, Yasukawa K, Saito H, Terai M.
    J Allergy Clin Immunol; 2008 Nov; 122(5):1008-1013.e8. PubMed ID: 18930517
    [Abstract] [Full Text] [Related]

  • 16. Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.
    Khowsathit P, Hong-Hgam C, Khositseth A, Wanitkun S.
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1121-6. PubMed ID: 12549785
    [Abstract] [Full Text] [Related]

  • 17. Monitoring of the serum proteome in Kawasaki disease patients before and after immunoglobulin therapy.
    Zhang L, Jia HL, Huang WM, Liu CW, Hua L, Liu TC, Mao LJ, Xu YF, Li W, Xia SL, Gan YY, Deng L, Zhang G.
    Biochem Biophys Res Commun; 2014 Apr 25; 447(1):19-25. PubMed ID: 24690176
    [Abstract] [Full Text] [Related]

  • 18. Down-regulation of TLR2, 3, 9 and Signaling Mediators, MyD88 and TRIF, Gene Transcript Levels in Patients with Kawasaki Disease Treated with IVIG.
    Mortazavi SH, Amin R, Alyasin S, Kashef S, Karimi MH, Babaei M, Younesi V.
    Iran J Allergy Asthma Immunol; 2015 Apr 25; 14(2):188-97. PubMed ID: 25780885
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
    Arthritis Rheum; 2013 Mar 25; 65(3):805-14. PubMed ID: 23440694
    [Abstract] [Full Text] [Related]

  • 20. Expression of myeloid-related protein-8 and -14 in patients with acute Kawasaki disease.
    Hirono K, Foell D, Xing Y, Miyagawa-Tomita S, Ye F, Ahlmann M, Vogl T, Futatani T, Rui C, Yu X, Watanabe K, Wanatabe S, Tsubata S, Uese K, Hashimoto I, Ichida F, Nakazawa M, Roth J, Miyawaki T.
    J Am Coll Cardiol; 2006 Sep 19; 48(6):1257-64. PubMed ID: 16979015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.